NEW YORK (

TheStreet

) -- Shares of

China-biotics

(Nasdaq:

CHBT

) were gapping up Monday morning with an open price 10.1% higher than Friday's closing price. The stock closed at $6.04 Friday and opened today's trading at $6.65.

The average volume for China-biotics has been 662,400 shares per day over the past 30 days. China-biotics has a market cap of $142 million and is part of the

health care

sector and

drugs

industry. Shares are down 58.9% year to date as of the close of trading on Friday.

China-Biotics, Inc. engages in the research, development, production, marketing, and distribution of probiotics products in the People's Republic of China. Its products contain live microbial food supplements, which beneficially affect the host by improving its intestinal microbial balance. The company has a P/E ratio of five, equal to the average drugs industry P/E ratio and below the S&P 500 P/E ratio of 17.7.

TheStreet Recommends

TheStreet Ratings rates China-biotics as a

hold

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and growth in earnings per share. However, as a counter to these strengths, we also find weaknesses including weak operating cash flow and a generally disappointing performance in the stock itself. You can view the full

China-biotics Ratings Report

.

Get more investment ideas from our

investment research center

.

Interested in other stocks that are gapping up? Get free SMS text alerts sent to you when the action happens by texting

UP

to 95370 or select from

multiple alert options

.

null